|
Respironics, Inc. BiPAP A40; Ventilator, Continuous, Minimal Ventilatory Support, Facility Use
|
Back to Search Results |
|
| Model Number |
1076538 |
| Medical Device Problem Code |
Degraded (1153)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/09/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
A bipap a40 device was returned to a third-party service center in reference to the voluntary field safety notice/recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.There is no allegation of serious or permanent harm or injury.The device was not documented to be in patient use.During the evaluation of the device, the service technician observed foam particles inside the assembly.The foam insulation needs to be replaced to resolve the issue.Additionally, the evaluation of the device data identified unrelated error codes.These error codes are consistent with normal device operation and expected use conditions and are not considered reportable under medical device reporting requirements.No evidence was identified to suggest that these error codes contributed to or caused the reported event.The service technician also noted tobacco and dirt/dust contamination.No repair was performed.The device was scrapped by the service center after the evaluation was completed.
|
| |
|
Additional Manufacturer Narrative
|
|
The affected products with field complaints alleging pe-pur foam degradation have undergone the establishment of complaint codes specifically identifying foam degradation, for the a series.A field correction action (fsca 2021-05-a) was initiated, and medical device recall letters were issued.A field action was initiated to replace pe-pur foam in affected products; degradation was added to the respective dfmeas and the risk management file¿ (b)(4) v27 (merlin risk matrix) was updated to include hazards associated with foam degradation based on complaints analyzed through various health hazard evaluations (hhes).Risk tags ¿ mduri001, mdtox002 reflected the safety risk assessment of design containing the affected pe-pur foam.These complaints were monitored and trended in accordance with the complaint trending procedures.If the complaints were determined to meet the criteria for escalation, they were escalated for risk assessment through the post market clinical escalation process.As of the date of submission for this report, there is no indication that complaints for the failure in question have led to unacceptable levels of severity or probabilities of harm, and therefore no further action will be pursued.Dhr review not required.The device mentioned in this complaint has exceeded its useful life per the applicable ifu.
|
| |
|
Search Alerts/Recalls
|
|
|